News
13h
MedPage Today on MSNRemove Boxed Warning on Hormone Therapy for Menopause, FDA Panel SaysA panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
The U.S. Food and Drug Administration is planning to ask Sarepta Therapeutics to voluntarily stop all shipments of its gene ...
US Food and Drug Administration Commissioner Marty Makary said he’s “taking a hard look” at whether a gene therapy from ...
Health Secretary Robert F. Kennedy Jr. and other Trump officials are signaling their interest in approving psychedelic drugs ...
The Food and Drug Administration plans to ask Sarepta Therapeutics Inc. to pause shipments of its Elevidys treatment after ...
16hon MSN
The U.S. Food and Drug Administration will request Sarepta Therapeutics to voluntarily stop all shipments of its gene therapy ...
Shares of Sarepta Therapeutics (NASDAQ:SRPT) continued to fall on Friday as Reuters reported that the U.S. FDA plans to ...
15h
Asianet Newsable on MSNFDA Is Reportedly ‘Taking A Hard Look’ To Evaluate Whether Sarepta’s Gene Therapy Elevidys Should Remain On The MarketThe growing number of fatalities is raising questions about the future of Sarepta’s therapies and the regulatory path for ...
A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results